Patents Assigned to Blend Therapeutics
  • CABAZITAXEL-PLATINUM NANOPARTICLES AND METHODS OF USING SAME
    Publication number: 20140378427
    Abstract: The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum compound having a heterocycle ligand. Cabazitaxel-platinum nanoparticles are disclosed herein, as well as methods of making and using the same.
    Type: Application
    Filed: March 17, 2014
    Publication date: December 25, 2014
    Applicant: Blend Therapeutics
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood
  • PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20140088066
    Abstract: The present disclosure relates to novel pharmaceutical compositions comprising a nanoparticle associated with, tether to, or encapsulating a platinum-based active pharmaceutical agent. The platinum-based drug is released from the nanoparticles in a controlled fashion. Also contemplated are methods of making the nanoparticles, as well as methods for using them in the treatment or prevention of diseases or conditions. One embodiment relates to phenanthriplatin nanoparticles and methods of using and making the same.
    Type: Application
    Filed: September 11, 2013
    Publication date: March 27, 2014
    Applicant: Blend Therapeutics
    Inventors: Mark T. Bilodeau, Craig A. Dunbar, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood, Benoît Moreau, Rajesh Shinde, Melaney Bouthillette